Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Nova Minerals
NVA
CN Stock MarketDetailed Quotes
002581 Shandong Sinobioway Biomedicine
- 6.61
- +0.60+9.98%
Market Closed Apr 30 15:00 CST
4.36BMarket Cap-29.77P/E (TTM)
6.61High5.69Low429.47KlotVolume5.69Open6.01Pre Close269.79MTurnover10.72%Turnover RatioLossP/E (Static)659.74MShares14.4352wk High2.31P/B2.65BFloat Cap5.6952wk Low6.61Limit Up400.79MShs Float71.85Historical High5.41Limit Down15.31%Amplitude4.39Historical Low--Dividend TTM6.28Avg Price138.31KlotAsk--Div YieldTTM100Lot Size268.78KlotBid
Shandong Sinobioway Biomedicine Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -35.56%65.53M | -5.33%448.75M | 0.82%325.77M | 8.05%200.77M | 22.08%101.69M | 4.85%474.02M | -2.24%323.11M | -11.95%185.82M | -10.68%83.3M | -2.69%452.08M |
| Refunds of taxes and levies | -27.21%7.66K | ---- | -11.94%10.52K | -4.61%10.52K | -4.61%10.52K | ---- | -99.79%11.95K | -99.80%11.03K | -98.35%11.03K | 294.82%5.82M |
| Net deposit increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in borrowings from central bank | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in placements from other financial institutions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash received from interests, fees and commissions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in repurchase business capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Premiums received from original insurance contracts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net cash received from reinsurance business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in deposits from policyholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in funds disbursed | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net cash received from trading securities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash received relating to other operating activities | -5.45%1.49M | 188.44%256.49M | -89.83%6.02M | -60.13%4.73M | -9.89%1.57M | 100.00%88.92M | 323.06%59.25M | 42.69%11.85M | -71.01%1.74M | 87.45%44.46M |
| Cash inflows from operating activities | -35.10%67.02M | 25.28%705.24M | -13.22%331.8M | 3.96%205.51M | 21.42%103.27M | 12.06%562.94M | 9.17%382.36M | -12.14%197.68M | -14.89%85.05M | 2.57%502.37M |
| Goods services cash paid | 77.53%5.57M | 12.12%54.73M | -13.89%14.75M | -49.79%7.01M | -64.13%3.14M | 0.31%48.81M | -62.97%17.13M | -54.15%13.95M | -45.75%8.75M | -2.93%48.66M |
| Staff behalf paid | -8.43%24.92M | -15.62%78.51M | -12.69%62.67M | -12.57%45.16M | -10.01%27.21M | -13.13%93.04M | -21.54%71.77M | -22.95%51.65M | -33.29%30.24M | -0.86%107.11M |
| All taxes paid | -29.91%4.18M | -28.81%22.6M | -33.91%17.06M | -44.54%10.03M | -47.11%5.96M | 48.99%31.75M | 113.06%25.82M | 144.21%18.08M | 133.31%11.27M | -2.17%21.31M |
| Net loan and advance increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net deposit in central bank and institutions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net lend capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash paid for fees and commissions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash paid for indemnity of original insurance contract | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Policy dividend cash paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash paid relating to other operating activities | 10.73%90.97M | 30.55%555.94M | 7.47%285.63M | 12.87%193.95M | 29.17%82.16M | 12.13%425.85M | 16.93%265.77M | 24.16%171.84M | -10.20%63.61M | 6.72%379.77M |
| Cash outflows from operating activities | 6.05%125.64M | 18.74%711.79M | -0.10%380.11M | 0.24%256.14M | 4.05%118.47M | 7.65%599.45M | 0.89%380.49M | 5.04%255.53M | -16.96%113.86M | 3.93%556.85M |
| Net cash flows from operating activities | -285.59%-58.61M | 82.07%-6.55M | -2,675.97%-48.31M | 12.46%-50.63M | 47.23%-15.2M | 33.00%-36.51M | 106.97%1.88M | -216.40%-57.84M | 22.51%-28.81M | -18.41%-54.49M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | ---- | ---- | --28.31K | --0 | ---- | ---- | --0 |
| Cash received from returns on investments | ---- | 5.05%269.1M | 5.46%269.1M | 16,322.67%269.1M | 3,242.28%53.82M | --256.17M | --255.16M | --1.64M | --1.61M | --0 |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -87.17%3.21M | 71.19%8.17M | 687.06%28.85M | 856.36%25.35M | 4,446.30%25.05M | -80.48%4.77M | 7,443.21%3.67M | --2.65M | --551K | 149,442.32%24.45M |
| Net cash received from disposal of subsidiaries and other business units | ---- | --73.75M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash received relating to other investing activities | ---- | --25.06M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | 340.00%22M |
| Cash inflows from investing activities | -95.93%3.21M | 44.11%376.07M | 15.12%297.95M | 6,764.37%294.45M | 3,549.24%78.87M | 461.82%260.97M | 532,465.00%258.83M | --4.29M | --2.16M | 825.98%46.45M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 4,920.88%6.17M | 108.71%9.01M | -87.90%3.54M | -99.59%116.82K | -99.67%122.93K | -86.27%4.32M | -34.10%29.23M | -23.93%28.82M | 340.58%37.35M | -48.29%31.46M |
| Cash paid to acquire investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --50M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Impawned loan net increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.4M |
| Cash outflows from investing activities | 4,920.88%6.17M | 108.71%9.01M | -87.90%3.54M | -99.59%116.82K | -99.67%122.93K | -94.91%4.32M | -69.02%29.23M | -23.93%28.82M | 340.58%37.35M | 39.48%84.87M |
| Net cash flows from investing activities | -103.76%-2.96M | 43.02%367.06M | 28.23%294.42M | 1,299.91%294.34M | 323.81%78.75M | 768.09%256.65M | 343.46%229.6M | 35.25%-24.53M | -315.09%-35.19M | 31.19%-38.42M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash from borrowing | ---- | -80.01%2.77M | ---- | ---- | ---- | -93.92%13.84M | -94.54%10M | -89.78%8.23M | ---- | 4.36%227.5M |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 845.11%70.83M |
| Cash inflows from financing activities | ---- | -80.01%2.77M | ---- | ---- | ---- | -95.36%13.84M | -94.54%10M | -89.78%8.23M | --0 | 32.30%298.33M |
| Borrowing repayment | ---- | -93.20%10M | -81.22%10.94M | -94.89%944.75K | ---- | -35.81%147M | -42.59%58.27M | -69.96%18.47M | -94.35%3.47M | 21.81%229M |
| Dividend interest payment | ---- | -98.27%177.36K | -96.98%177.36K | -95.83%166.97K | -95.76%93.36K | 27.77%10.28M | -10.38%5.88M | 1.89%4M | 13.90%2.2M | 19.92%8.04M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash payments relating to other financing activities | ---- | -99.17%560.6K | ---- | ---- | ---- | 405.47%67.7M | --3.07M | --3.07M | --3.07M | -47.05%13.39M |
| Cash outflows from financing activities | ---- | -95.23%10.74M | -83.45%11.12M | -95.65%1.11M | -98.93%93.36K | -10.17%224.98M | -37.79%67.22M | -60.96%25.54M | -86.22%8.74M | 13.83%250.44M |
| Net cash flows from financing activities | ---- | 96.22%-7.97M | 80.56%-11.12M | 93.58%-1.11M | 98.93%-93.36K | -540.86%-211.14M | -176.11%-57.22M | -214.87%-17.31M | -151.23%-8.74M | 772.07%47.89M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---- | 107.54%34.24 | --255.64 | --274.43 | --131.63 | -110.49%-453.92 | --0 | ---- | ---- | 550.39%4.33K |
| Net increase in cash and cash equivalents | -197.04%-61.57M | 3,816.55%352.54M | 34.86%234.99M | 343.35%242.59M | 187.24%63.45M | 120.00%9M | 478.66%174.25M | -142.59%-99.69M | -154.48%-72.74M | 53.29%-45M |
| Add:Begin period cash and cash equivalents | 232.25%504.34M | 6.30%151.8M | 6.30%151.8M | 6.30%151.8M | 6.30%151.8M | -23.96%142.79M | -23.96%142.79M | -23.96%142.79M | -23.96%142.79M | -33.91%187.8M |
| End period cash equivalent | 105.70%442.76M | 232.25%504.34M | 22.00%386.79M | 814.92%394.39M | 207.25%215.25M | 6.30%151.8M | 123.62%317.04M | -70.62%43.11M | -56.00%70.06M | -23.96%142.79M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion with explanatory notes |
| Auditor | -- | Shenzhen Guangshen Certified Public Accountants Firm (General Partnership) | -- | -- | -- | Shenzhen Guangshen Certified Public Accountants Firm (General Partnership) | -- | -- | -- | Shenzhen Guangshen Certified Public Accountants Firm (General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts